Month: April 2017
Congressional hearings. Federal investigations. Consumer outrage. In the wake of developments like these, many drug company executives are laying low. Their favored business models, based on raising drug prices indiscriminately, are now seen as a liability; many pharmaceutical companies are curbing increases on their products and accepting that this once-lucrative jig may be up.
More than two dozen doctors, pharmacists and business owners were charged Thursday in an alleged $40 million medical-insurance scam in Orange County and elsewhere that officials said “played with patients’ lives.”
As congressional Republicans’ efforts to repeal and replace the Affordable Care Act remain in limbo, the Trump administration and some states are taking steps to help insurers cover the cost of their sickest patients, a move that industry analysts say is critical to keeping premiums affordable for plans sold on the law’s online marketplaces in 2018.
Congressional negotiators on Tuesday inched toward a potential agreement on a catchall spending bill that would deny President Donald Trump’s request for immediate funding to construct a wall along the Mexico border. The emerging measure would increase the defense budget and eliminate the threat of a government shutdown on Trump’s 100th day in office this Saturday.
Your federal income taxes are due April 18 and, likely for several million people, so is a fine for failing to get health insurance.
A much tighter sign-up deadline and coverage delays will be waiting for some health insurance customers now that President Donald Trump's administration has finished a plan designed to stabilize shaky insurance markets.
Democrats are up in arms over President Donald Trump's threats to deny payments to health insurers under Barack Obama's health care law.
With deadlines looming to file plans for next year’s Affordable Care Act marketplaces, health insurers are struggling to respond to mixed signals from the Trump administration, delaying key business decisions and scouring Twitter for hints from Washington about the law’s future.
Buoyed by Congress’ failed attempt last week to replace the Affordable Care Act, California officials, health advocates and insurance executives are pressing forward on a new phase of resistance against GOP efforts to weaken the health care law.
The pharmaceutical industry for years has fended off calls for government to controls prices despite the growing uproar over soaring prescription drug costs.,